Nucleate Baltics: How do life sciences get funded in 2026?
How do life sciences get funded in 2026?
➡️ Biotech and deep tech startups don’t grow on ideas alone - they grow on grants, capital and trust.
🧫 Join us for a panel discussion at Startup House Riga and hear what’s important from founders and investors building the future of life sciences. Whether you’re a student, an aspiring founder, or simply curious about how life science ideas can turn into real-world impact - this event is for you!
Moderated by Alīna Reķēna, a biotechnology PhD graduate from Tallinn University of Technology and Nucleate Latvia member, the discussion will feature panelists from science funding, venture capital and entrepreneurship, each bringing extensive experience in financing life sciences ventures.
👥 Meet our panelists:
Marija Plotniece (Latvian Council of Science)
Sigvards Krongorns (Verge HealthTech Fund)
Imants Zudāns (entrepreneur and business development advisor)
🔬This event will explore:
How public funding for life sciences works in Latvia and Europe
How venture capital evaluates deep tech risk
What founders should understand about equity
How students can position themselves for leadership and venture roles
📅 When and where:
April 22, 18:30 (18:00-18:30 -> arrival and mingling, 18:30 -> start of discussion)
📍 Startup House Riga, Riga
🕕 Format: 45-minute panel + networking
🥤 Light refreshments & drinks provided
🎟️ Free entry with mandatory registration
🌍 Language: English
Come and find out who funds biotech, how the money flows - and how you can position yourself to be part of it.
About the Host:
Nucleate is a 501(c)(3) nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 41 geographic regions and participation from over 280 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit www.nucleate.org for more information, and visit https://nucleate.org/privacy-policy/ to read our privacy policy.
We want to thank our HQ supporters for championing our open-access mission and empowering the next generation of biotech entrepreneurs!
Platinum: Eli Lilly and Company, Genentech, Alnylam Pharmaceuticals, MilliporeSigma
Philanthropic Support: Lyda Hill Philanthropies
Preferred Partners: Pillar VC, Amino Collective, Fenwick, Excedr, Mercury, Brex, Fedsprout, Browne Consulting
In-Kind Support: AcademicLabs, Lens.org